MITF maintains genome stability in non-melanocytic cell lineages and suppresses Hippo pathway signaling
Authors:
- Adrián López García de LomanaAdrián López García de Lomana
- Thejus B. VenkateshTVThejus B. Venkatesh
- Kritika KirtyKKKritika Kirty
- Snaevar SigurdssonSSSnaevar Sigurdsson
- Linda VidarsdottirLVLinda Vidarsdottir
- Ramile DilshatRDRamile Dilshat
- Maria R. BustosMBMaria R. Bustos
- Eirikur SteingrimssonESEirikur Steingrimsson
Preprint
Abstract
Microphthalmia-associated transcription factor (MITF) is crucial for development and survival of melanocytes and serves as a lineage-specific oncogene that is amplified in 10-20% of melanomas. The role of MITF in pathways maintaining genome integrity, such as DNA replication, DNA repair and mitosis has been extensively studied in melanocytes. In addition to its pro-survival role in melanoma, recent studies have shown that MITF expression has important implications for cancer progression and treatment in other cancer types. Nevertheless, studies on the role of MITF in other tissues are scarce. Here, we show that depletion of MITF causes genome instability in non-melanocytic cell lineages, which results in activation of P53, cell cycle arrest and apoptosis. Moreover, we show that P53 activation in MITF depleted cells is dependent on LATS2, a key kinase in the Hippo pathway. Finally, we show that this LATS2 mediated upregulation of P53 is ATR dependent. Collectively, this study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage, which might contribute to the tumor suppressive function of MITF.Keywords
Funding Information
- The Icelandic research fund (163315-05)
- The Icelandic research fund (228533-051)
- The Icelandic research fund (217768)
- The Icelandic Cancer Society research fund (2021)
- The Icelandic Cancer Society research fund (2023)
This publication has 66 references indexed in Scilit:
- Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasisInternational Immunopharmacology, 2023
- A central role for regulated protein stability in the control of TFE3 and MITF by nutrientsMolecular Cell, 2023
- Hallmarks of DNA replication stressMolecular Cell, 2022
- Micronuclei as biomarkers of DNA damage, aneuploidy, inducers of chromosomal hypermutation and as sources of pro-inflammatory DNA in humansMutation Research - Reviews in Mutation Research, 2020
- Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2019
- Putting p53 in ContextCell, 2017
- Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cellsTumor Biology, 2014
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer CellsCell, 2011
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009
- MITF: master regulator of melanocyte development and melanoma oncogeneTrends in Molecular Medicine, 2006